Status:

UNKNOWN

Phacoemulsification in Acute Congestive Glaucoma

Lead Sponsor:

Hany Mahmoud

Conditions:

Glaucoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Acute primary angle closure (APAC) is usually caused by an abrupt closure of the trabecular meshwork in the anterior chamber angle that leads to a sudden rise in intraocular pressure (IOP). APAC is a ...

Eligibility Criteria

Inclusion

  • patients with acute congestive glaucoma

Exclusion

  • people under 18 years

Key Trial Info

Start Date :

February 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 20 2022

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT05289453

Start Date

February 20 2022

End Date

June 20 2022

Last Update

March 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hany Mahmoud

Sohag, Egypt

Phacoemulsification in Acute Congestive Glaucoma | DecenTrialz